Jonathan Klein concentrates his practice in the areas of mergers and acquisitions, private equity, corporate finance, and securities matters for both domestic and international clients. Mr. Klein heads the New York corporate and finance department.

Mr. Klein has represented public and private companies in negotiated acquisitions and dispositions (including mergers, stock transactions, asset deals and divestitures), as well as bidders in contested transactions. Mr. Klein’s private equity experience includes domestic and international leveraged transactions for both financial and strategic parties. His corporate finance experience includes public and private offerings of equity and debt securities.

Mr. Klein's general corporate practice includes advising public companies on SEC compliance and reporting issues, internal investigations, joint ventures, licensing, and distribution agreements and providing general corporate advice and counsel to public and private companies, partnerships, and individuals. He regularly counsels senior management, corporate boards and controlling stockholders with respect to acquisitions, dispositions, buyouts and general corporate and securities matters.

Mr. Klein has represented US and foreign clients in connection with cross-border acquisitions, divestitures, joint ventures, private financings, loan restructurings and workouts, and general corporate matters.

Representative Matters

• Representation of Invitrogen Corporation in connection with its $6.7 billion merger with Applera Corporation (Applied Biosystems, Inc.).
• Representation of The Rank Group plc. in connection with its sale of The Hard Rock International to the Seminole Indian Tribe of Florida.
• Representation of Emirates Investment & Development Corp. in connection with its acquisition of Sino Swearingen Aircraft Corp.
• Representation of Arc International in connection with its sale of Mikasa Inc. to Lifetime Brands.
• Representation of China Hydroelectric Corporation in connection with $200 million private financing transaction.
• Representation of Carat Duchatelet in connection with its acquisition of Centigon Holdings from BAE Systems.
• Representation of Atkins Nutritionals in connection with its sale to North Castle Partners
• Representation of CK Life Sciences in acquisition of Vitaquest International.
• Representation of NTL Europe, Inc. in the restructuring and sale of Cablecom Communications Corp., the largest Swiss cable company.
• Representation of NTL Europe, Inc. in connection with its going-private transaction.
• Representation of Manseuto Ventures in connection with the acquisition of Inc. and Fast Company magazines.
• Representation of Cavalry Investments in connection with investment by Bear Stearns Merchant Banking.

REGISTRATIES

• New York